[HTML][HTML] Effectiveness and safety of dabigatran in atrial fibrillation patients with severe obesity: a real-world retrospective cohort study

CW Huang, L Duan, J An, JJ Sim, MS Lee - Journal of General Internal Medicine - Springer
Background Direct oral anticoagulants such as dabigatran are the preferred anticoagulant in
treating atrial fibrillation (AF) patients due to their effectiveness and safety. Whether this …

[PDF][PDF] Effectiveness and Safety of Dabigatran in Atrial Fibrillation Patients with Severe Obesity: a Real-World Retrospective Cohort Study

MS Lee - 2021 - researchgate.net
BACKGROUND: Direct oral anticoagulants such as dabigatran are the preferred
anticoagulant in treating atrial fibrillation (AF) patients due to their effectiveness and safety …

Effectiveness and Safety of Dabigatran in Atrial Fibrillation Patients with Severe Obesity: a Real-World Retrospective Cohort Study.

CW Huang, L Duan, J An, JJ Sim… - JGIM: Journal of …, 2022 - search.ebscohost.com
Background: Direct oral anticoagulants such as dabigatran are the preferred anticoagulant
in treating atrial fibrillation (AF) patients due to their effectiveness and safety. Whether this …

Effectiveness and Safety of Dabigatran in Atrial Fibrillation Patients with Severe Obesity: a Real-World Retrospective Cohort Study.

CW Huang, L Duan, J An, JJ Sim… - Journal of General Internal …, 2021 - europepmc.org
Background Direct oral anticoagulants such as dabigatran are the preferred anticoagulant in
treating atrial fibrillation (AF) patients due to their effectiveness and safety. Whether this …

Effectiveness and Safety of Dabigatran in Atrial Fibrillation Patients with Severe Obesity: a Real-World Retrospective Cohort Study

CW Huang, L Duan, J An, JJ Sim… - Journal of General …, 2022 - search.proquest.com
Background Direct oral anticoagulants such as dabigatran are the preferred anticoagulant in
treating atrial fibrillation (AF) patients due to their effectiveness and safety. Whether this …

Effectiveness and Safety of Dabigatran in Atrial Fibrillation Patients with Severe Obesity: a Real-World Retrospective Cohort Study

CW Huang, L Duan, J An, JJ Sim… - Journal of general …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Direct oral anticoagulants such as dabigatran are the preferred anticoagulant in
treating atrial fibrillation (AF) patients due to their effectiveness and safety. Whether this …

[HTML][HTML] Effectiveness and Safety of Dabigatran in Atrial Fibrillation Patients with Severe Obesity: a Real-World Retrospective Cohort Study

CW Huang, L Duan, J An, JJ Sim… - Journal of General Internal …, 2022 - ncbi.nlm.nih.gov
Background Direct oral anticoagulants such as dabigatran are the preferred anticoagulant in
treating atrial fibrillation (AF) patients due to their effectiveness and safety. Whether this …

Effectiveness and Safety of Dabigatran in Atrial Fibrillation Patients with Severe Obesity: a Real-World Retrospective Cohort Study.

CW Huang, L Duan, J An, JJ Sim… - Journal of General Internal …, 2021 - europepmc.org
Background Direct oral anticoagulants such as dabigatran are the preferred anticoagulant in
treating atrial fibrillation (AF) patients due to their effectiveness and safety. Whether this …